Latest / Decera Clinical Education Oncology Podcast
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
In this episode, Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, answer questions from a live webinar providing their thoughts on how to select the optimal therapy for patients with relapse/refractory multiple myeloma. Topics include:
Treatment after first relapsed
Optimal use of CAR T-cell therapy
When to use selinexor and belantamab mafodotin
COVID-19 vaccinations for patients with myeloma
Presenters:
Paul G. Richardson, MD
R. J. Corman Professor of Medicine
Harvard Medical School
Clinical Program Leader
Director of Clinical Research
Jerome Lipper Multiple Myeloma Center…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.